mesalamine has been researched along with Hepatic Failure in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filipec Kanizaj, T | 1 |
| Mijic, M | 1 |
1 review available for mesalamine and Hepatic Failure
| Article | Year |
|---|---|
Inflammatory bowel disease in liver transplanted patients.
Topics: Algorithms; Anastomosis, Surgical; Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Femal | 2017 |